Company

BioPartners X Signs RMB 227 Million Technology Transfer Deal with CAMS for CD132 Autoimmune Antibody
Auto-immuneBioPartners X

BioPartners X Signs RMB 227 Million Technology Transfer Deal with CAMS for CD132 Autoimmune Antibody

BioPartners X announced that it has entered into a technology transfer agreement with the Hospital of Dermatology, Chinese Academy of Medical Sciences (CAMS) for an innovative CD132‑targeting monoclonal antibody, with…

Zhejiang Garden Biopharmaceutical and Guangzhou National Laboratory Form Joint Venture to Develop 25‑Hydroxycholesterol – A Prodrug‑Class Broad‑Spectrum Antiviral Program

Zhejiang Garden Biopharmaceutical and Guangzhou National Laboratory Form Joint Venture to Develop 25‑Hydroxycholesterol – A Prodrug‑Class Broad‑Spectrum Antiviral Program

Adalvo and Jiangsu Sinopep‑Allsino Forge Strategic Partnership – Combining Peptide and Oligonucleotide Manufacturing Expertise with Commercial Reach Across 160+ Markets

Adalvo and Jiangsu Sinopep‑Allsino Forge Strategic Partnership – Combining Peptide and Oligonucleotide Manufacturing Expertise with Commercial Reach Across 160+ Markets

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Tonghua Dongbao to Sell Stake in Amoytop Biotech for USD 181 Million
Amoytop BiotechSHA: 600867

Tonghua Dongbao to Sell Stake in Amoytop Biotech for USD 181 Million

Shandong Boan Biotechnology Partners with HKUST for Biomedicine Innovation
AIBiotech

Shandong Boan Biotechnology Partners with HKUST for Biomedicine Innovation

PacBio Appoints Haorui Gene as Official Distributor in China
Haorui GeneNASDAQ: PACB

PacBio Appoints Haorui Gene as Official Distributor in China

Zhongsheng Pharma's Anruiwei Receives NMPA Approval for Influenza A
Product approvalsSHE: 002317

Zhongsheng Pharma’s Anruiwei Receives NMPA Approval for Influenza A

Show More